Emma, a person who has IgA nephropathy, discusses her experience with diagnosis and treatment. She also discusses the importance of communication with medical professionals and she recommends avoiding searching for treatment options online.
Lauren Levy, MS, RDN, CSR, owner of Happy Health Nutrition, LLC, discusses considerations for kidney-friendly diets for patients with IgA nephropathy. She also discusses what parts of the…
Josh Galdi, PharmD, BCPS and Hannah N. Lambert, PharmD discuss the current understanding of IgA nephropathy with Anor Shaw, MD. They explore the nature of this common glomerular…
Professor Jonathan Barratt, head of the Renal Research Group within the College of Life Sciences at the University of Leicester, discusses the latest advancements in the treatment of…
Clarissa Tio, MD, a nephrologist at the University of Mississippi, moderates a discussion between Ariana Barton, a patient living with IgA nephropathy and a patient advocate, Joshua Samuels,…
This video discusses the risk factors for IgA nephropathy, a disease with no single known cause. While anyone can develop it, certain groups are at higher risk, including…
Anand Reddy, MRCP (UK), FACP, FASN, Permian Regional Medical Center, Andrews, Texas; and Richard Lafayette, MD, FASN, professor of medicine and director of the Stanford Glomerular Disease Center,…
Dawn J. Caster, MD, FASN, associate professor of medicine, Division of Nephrology & Hypertension, University of Louisville School of Medicine, Louisville, Kentucky, discusses IgA nephropathy, including when to…
This video discusses the management of IgA nephropathy, a common and incurable kidney disease. Treatment aims to control the disease and delay kidney damage progression. Lifestyle changes, such…
In this heartfelt video, four different patients share their journies with IgA nephropathy, kidney failure, and the eventual need for a transplant. Initially unaware of their conditions, they…
Heather N. Reich, MD, CM, PhD, FRCPC, Oreopoulos-Baxter Division Director of Nephrology, University of Toronto, discusses translating new clinical trials in IgA nephropathy, a kidney disease. Dr Reich…
